Larimar Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
103.9M
on 2026-06-30, from 63.8M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3 of 2024-05-09. Not read yet. S-3 ↗
1 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-04 is not read yet.
Cash
Four quarters of operating cash flow to 2026-06-30 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-02-25 | Public offering | 20,000,000 | $5.00 | $100.0M | 424B5 ↗ |
| 2025-07-29 | Public offering | 18,750,000 | $3.20 | $60.0M | 424B5 ↗ |